Dunbar PR - Search Results

1

Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune Diseases.

Schwabe C, Rosenstock B, Doan T, Hamilton P, Dunbar PR, Eleftheraki AG, Joseph D, Hilbert J, Schoelch C, Padula SJ, Steffgen J. Schwabe C, et al. Among authors: dunbar pr. J Clin Pharmacol. 2018 Dec;58(12):1566-1577. doi: 10.1002/jcph.1278. Epub 2018 Aug 16. J Clin Pharmacol. 2018. PMID: 30113724 Free PMC article. Clinical Trial.

2

Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study.

Gane E, Verdon DJ, Brooks AE, Gaggar A, Nguyen AH, Subramanian GM, Schwabe C, Dunbar PR. Gane E, et al. Among authors: dunbar pr. J Hepatol. 2019 Nov;71(5):900-907. doi: 10.1016/j.jhep.2019.06.028. Epub 2019 Jul 12. J Hepatol. 2019. PMID: 31306680 Clinical Trial.

3

Ex Vivo Human Adipose Tissue Derived Mesenchymal Stromal Cells (ASC) Are a Heterogeneous Population That Demonstrate Rapid Culture-Induced Changes.

Brooks AES, Iminitoff M, Williams E, Damani T, Jackson-Patel V, Fan V, James J, Dunbar PR, Feisst V, Sheppard HM. Brooks AES, et al. Among authors: dunbar pr. Front Pharmacol. 2020 Feb 20;10:1695. doi: 10.3389/fphar.2019.01695. eCollection 2019. Front Pharmacol. 2020. PMID: 32153389 Free PMC article.

4

The natural compound, formononetin, extracted from Astragalus membranaceus increases adipocyte thermogenesis by modulating PPARγ activity.

Nie T, Zhao S, Mao L, Yang Y, Sun W, Lin X, Liu S, Li K, Sun Y, Li P, Zhou Z, Lin S, Hui X, Xu A, Ma CW, Xu Y, Wang C, Dunbar PR, Wu D. Nie T, et al. Among authors: dunbar pr. Br J Pharmacol. 2018 May;175(9):1439-1450. doi: 10.1111/bph.14139. Epub 2018 Mar 14. Br J Pharmacol. 2018. PMID: 29315511 Free PMC article.

5

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.

Cebon JS, Gore M, Thompson JF, Davis ID, McArthur GA, Walpole E, Smithers M, Cerundolo V, Dunbar PR, MacGregor D, Fisher C, Millward M, Nathan P, Findlay MPN, Hersey P, Evans TRJ, Ottensmeier CH, Marsden J, Dalgleish AG, Corrie PG, Maria M, Brimble M, Williams G, Winkler S, Jackson HM, Endo-Munoz L, Tutuka CSA, Venhaus R, Old LJ, Haack D, Maraskovsky E, Behren A, Chen W. Cebon JS, et al. Among authors: dunbar pr. J Immunother Cancer. 2020 Apr;8(1):e000410. doi: 10.1136/jitc-2019-000410. J Immunother Cancer. 2020. PMID: 32317292 Free PMC article. Clinical Trial.

6

Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry.

Graham ES, Angel CE, Schwarcz LE, Dunbar PR, Glass M. Graham ES, et al. Among authors: dunbar pr. Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1):25-34. doi: 10.1177/039463201002300103. Int J Immunopathol Pharmacol. 2010. PMID: 20377992 Free article.

7

Identification of germinal centres in the lymph node of a patient with hyperimmunoglobulin M syndrome associated with congenital rubella.

Ameratunga R, Chen CJ, Koopmans W, Dunbar PR, Brewerton M, Lloydd R, Mansell CJ, van Vliet C, Woon ST. Ameratunga R, et al. Among authors: dunbar pr. J Clin Immunol. 2014 Oct;34(7):796-803. doi: 10.1007/s10875-014-0084-6. Epub 2014 Aug 12. J Clin Immunol. 2014. PMID: 25113848

8

Neuroserpin regulates human T cell-T cell interactions and proliferation through inhibition of tissue plasminogen activator.

Loef EJ, Brooks AES, Lorenz N, Birch NP, Dunbar PR. Loef EJ, et al. Among authors: dunbar pr. J Leukoc Biol. 2020 Jan;107(1):145-158. doi: 10.1002/JLB.2A1019-098RR. Epub 2019 Oct 31. J Leukoc Biol. 2020. PMID: 31667914

9

Synthesis and Evaluation of Novel TLR2 Agonists as Potential Adjuvants for Cancer Vaccines.

Lu BL, Williams GM, Verdon DJ, Dunbar PR, Brimble MA. Lu BL, et al. Among authors: dunbar pr. J Med Chem. 2020 Mar 12;63(5):2282-2291. doi: 10.1021/acs.jmedchem.9b01044. Epub 2019 Aug 30. J Med Chem. 2020. PMID: 31418565

10

Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).

Koopmans W, Woon ST, Brooks AE, Dunbar PR, Browett P, Ameratunga R. Koopmans W, et al. Among authors: dunbar pr. J Clin Immunol. 2013 Jan;33(1):68-73. doi: 10.1007/s10875-012-9793-x. Epub 2012 Sep 15. J Clin Immunol. 2013. PMID: 22983507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters